161 related articles for article (PubMed ID: 28841687)
1. A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.
Buchakjian MR; Merritt NM; Moose DL; Dupuy AJ; Tanas MR; Henry MD
PLoS One; 2017; 12(8):e0183469. PubMed ID: 28841687
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered mouse model of pleomorphic liposarcoma: Immunophenotyping and histologic characterization.
Brown JM; Patel R; Smith-Fry K; Ward M; Oliver T; Jones KB
Neoplasia; 2024 Feb; 48():100956. PubMed ID: 38199172
[TBL] [Abstract][Full Text] [Related]
3. The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.
Hildebrand KM; Singla AK; McNeil R; Marritt KL; Hildebrand KN; Zemp F; Rajwani J; Itani D; Bose P; Mahoney DJ; Jirik FR; Monument MJ
PLoS One; 2021; 16(7):e0253864. PubMed ID: 34242269
[TBL] [Abstract][Full Text] [Related]
4. A spatially and temporally restricted mouse model of soft tissue sarcoma.
Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T
Nat Med; 2007 Aug; 13(8):992-7. PubMed ID: 17676052
[TBL] [Abstract][Full Text] [Related]
5. Methods to generate genetically engineered mouse models of soft tissue sarcoma.
Dodd RD; Añó L; Blum JM; Li Z; Van Mater D; Kirsch DG
Methods Mol Biol; 2015; 1267():283-95. PubMed ID: 25636474
[TBL] [Abstract][Full Text] [Related]
6. Development of mouse models of angiosarcoma driven by p53.
Salter DM; Griffin M; Muir M; Teo K; Culley J; Smith JR; Gomez-Cuadrado L; Matchett K; Sims AH; Hayward L; Henderson NC; Brunton VG
Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31221668
[TBL] [Abstract][Full Text] [Related]
7. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
8. Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.
Guijarro MV; Dahiya S; Danielson LS; Segura MF; Vales-Lara FM; Menendez S; Popiolek D; Mittal K; Wei JJ; Zavadil J; Cordon-Cardo C; Pandolfi PP; Hernando E
Am J Pathol; 2013 Jun; 182(6):2015-27. PubMed ID: 23708211
[TBL] [Abstract][Full Text] [Related]
9. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
10. Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency.
Choi J; Curtis SJ; Roy DM; Flesken-Nikitin A; Nikitin AY
Am J Pathol; 2010 Nov; 177(5):2645-58. PubMed ID: 20864684
[TBL] [Abstract][Full Text] [Related]
11. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
Franchi A; Massi D; Santucci M
Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
[TBL] [Abstract][Full Text] [Related]
12. Morphological and immunohistochemical characterization of sarcomatous tumors in wild-type and genetically engineered mice.
Rehg JE; Ward JM
Vet Pathol; 2012 Jan; 49(1):206-17. PubMed ID: 22146848
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous activation of Kras and inactivation of p53 induces soft tissue sarcoma and bladder urothelial hyperplasia.
Yang X; La Rosa FG; Genova EE; Huber K; Schaack J; Degregori J; Serkova NJ; Li Y; Su LJ; Kessler E; Flaig TW
PLoS One; 2013; 8(9):e74809. PubMed ID: 24058630
[TBL] [Abstract][Full Text] [Related]
14. A novel xenograft model with intrinsic vascularisation for growing undifferentiated pleomorphic sarcoma NOS in mice.
Tilkorn DJ; Daigeler A; Hauser J; Ring A; Stricker I; Schmitz I; Steinstraesser L; Steinau HU; Al-Benna S
J Cancer Res Clin Oncol; 2012 May; 138(5):877-84. PubMed ID: 22311184
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma.
Patel R; Mowery YM; Qi Y; Bassil AM; Holbrook M; Xu ES; Hong CS; Himes JE; Williams NT; Everitt J; Ma Y; Luo L; Selitsky SR; Modliszewski JL; Gao J; Jung SH; Kirsch DG; Badea CT
Mol Cancer Ther; 2023 Jan; 22(1):112-122. PubMed ID: 36162051
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
[TBL] [Abstract][Full Text] [Related]
17. Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle-based Chemotherapy in
Dodd RD; Scherer A; Huang W; McGivney GR; Gutierrez WR; Laverty EA; Ashcraft KA; Stephens VR; Yousefpour P; Saha S; Knepper-Adrian V; Floyd W; Chen M; Ma Y; Mastria EM; Cardona DM; Eward WC; Chilkoti A; Kirsch DG
Clin Cancer Res; 2020 Sep; 26(18):5036-5047. PubMed ID: 32718998
[TBL] [Abstract][Full Text] [Related]
18. Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging.
Yong C; Moose DL; Bannick N; Gutierrez WR; Vanneste M; Svensson R; Breheny P; Brown JA; Dodd RD; Cohen MB; Henry MD
PLoS One; 2020; 15(9):e0232807. PubMed ID: 32986721
[TBL] [Abstract][Full Text] [Related]
19. New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics.
Gibault L; Pérot G; Chibon F; Bonnin S; Lagarde P; Terrier P; Coindre JM; Aurias A
J Pathol; 2011 Jan; 223(1):64-71. PubMed ID: 21125665
[TBL] [Abstract][Full Text] [Related]
20. Unravelling undifferentiated soft tissue sarcomas: insights from genomics.
Hames-Fathi S; Nottley SWG; Pillay N
Histopathology; 2022 Jan; 80(1):109-121. PubMed ID: 34958500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
